Cargando…

Marathons and myasthenia gravis: a case report

BACKGROUND: The cardinal symptoms of auto-immune myasthenia gravis are fatigue and weakness. Endurance events such as marathon running would seem incompatible with this chronic disease. Many patients stop sport altogether. There is limited literature of patients with auto-immune myasthenia gravis un...

Descripción completa

Detalles Bibliográficos
Autores principales: Birnbaum, Simone, Sharshar, Tarek, Eymard, Bruno, Theaudin, Marie, Portero, Pierre, Hogrel, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142625/
https://www.ncbi.nlm.nih.gov/pubmed/30227849
http://dx.doi.org/10.1186/s12883-018-1150-0
_version_ 1783355859929137152
author Birnbaum, Simone
Sharshar, Tarek
Eymard, Bruno
Theaudin, Marie
Portero, Pierre
Hogrel, Jean-Yves
author_facet Birnbaum, Simone
Sharshar, Tarek
Eymard, Bruno
Theaudin, Marie
Portero, Pierre
Hogrel, Jean-Yves
author_sort Birnbaum, Simone
collection PubMed
description BACKGROUND: The cardinal symptoms of auto-immune myasthenia gravis are fatigue and weakness. Endurance events such as marathon running would seem incompatible with this chronic disease. Many patients stop sport altogether. There is limited literature of patients with auto-immune myasthenia gravis undergoing regular endurance exercise. CASE PRESENTATION: We report the case of a 36-year-old female who began long-distance running whilst experiencing initial symptoms of myasthenia gravis. She was diagnosed with auto-immune myasthenia gravis and whilst advised to stop all sport, her way of fighting and living with this chronic and unpredictable disease was to continue running to maintain a healthy body and mind. Despite suffering from ocular, bulbar and localized limb fatigability, she managed to complete multiple marathons and achieve disease stability with cholinesterase inhibitors. CONCLUSIONS: Marathon and half-marathon running lead to distinct changes in mediators of inflammation in an exercise-dose-dependent manner. Despite symptoms of weakness and fatigue in certain muscles in myasthenia gravis, physical exertion remains possible and may not worsen symptoms as demonstrated in this case and recent studies. The immunomodulatory role of exercise could be considered in this case however this hypothesis remains to be confirmed in future studies with quantitative data.
format Online
Article
Text
id pubmed-6142625
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61426252018-09-20 Marathons and myasthenia gravis: a case report Birnbaum, Simone Sharshar, Tarek Eymard, Bruno Theaudin, Marie Portero, Pierre Hogrel, Jean-Yves BMC Neurol Case Report BACKGROUND: The cardinal symptoms of auto-immune myasthenia gravis are fatigue and weakness. Endurance events such as marathon running would seem incompatible with this chronic disease. Many patients stop sport altogether. There is limited literature of patients with auto-immune myasthenia gravis undergoing regular endurance exercise. CASE PRESENTATION: We report the case of a 36-year-old female who began long-distance running whilst experiencing initial symptoms of myasthenia gravis. She was diagnosed with auto-immune myasthenia gravis and whilst advised to stop all sport, her way of fighting and living with this chronic and unpredictable disease was to continue running to maintain a healthy body and mind. Despite suffering from ocular, bulbar and localized limb fatigability, she managed to complete multiple marathons and achieve disease stability with cholinesterase inhibitors. CONCLUSIONS: Marathon and half-marathon running lead to distinct changes in mediators of inflammation in an exercise-dose-dependent manner. Despite symptoms of weakness and fatigue in certain muscles in myasthenia gravis, physical exertion remains possible and may not worsen symptoms as demonstrated in this case and recent studies. The immunomodulatory role of exercise could be considered in this case however this hypothesis remains to be confirmed in future studies with quantitative data. BioMed Central 2018-09-18 /pmc/articles/PMC6142625/ /pubmed/30227849 http://dx.doi.org/10.1186/s12883-018-1150-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Birnbaum, Simone
Sharshar, Tarek
Eymard, Bruno
Theaudin, Marie
Portero, Pierre
Hogrel, Jean-Yves
Marathons and myasthenia gravis: a case report
title Marathons and myasthenia gravis: a case report
title_full Marathons and myasthenia gravis: a case report
title_fullStr Marathons and myasthenia gravis: a case report
title_full_unstemmed Marathons and myasthenia gravis: a case report
title_short Marathons and myasthenia gravis: a case report
title_sort marathons and myasthenia gravis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142625/
https://www.ncbi.nlm.nih.gov/pubmed/30227849
http://dx.doi.org/10.1186/s12883-018-1150-0
work_keys_str_mv AT birnbaumsimone marathonsandmyastheniagravisacasereport
AT sharshartarek marathonsandmyastheniagravisacasereport
AT eymardbruno marathonsandmyastheniagravisacasereport
AT theaudinmarie marathonsandmyastheniagravisacasereport
AT porteropierre marathonsandmyastheniagravisacasereport
AT hogreljeanyves marathonsandmyastheniagravisacasereport